45 results
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
totaling RMB 3.7 million (USD 0.5 million) and a research and development tax incentive from the Australia government totaling RMB 6.3 million (USD 0.9 … Compensation
2019 Stock Incentive Plan
The Group adopted the 2019 Stock Incentive Plan (“2019 Plan”) and obtained Board’s approval on November 1, 2019, under
6-K
vm080941 xtb
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
S-8
EX-5.1
xwp rolssx
1 Jul 22
Registration of securities for employees
5:12pm
S-8
4smz j2da
1 Jul 22
Registration of securities for employees
5:12pm
S-8
ytcmwf9kt76mu
1 Jul 22
Registration of securities for employees
5:12pm
F-3/A
ula ex9zc
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
pbedsg 9nw8o2268nho1
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
2f6fafb49kbmdb8ygmo
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
EX-1.2
vfpb2ly5soc4z7o8
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-4.5
14xst5m
31 Mar 22
Annual report (foreign)
4:33pm
20-F
fhigz078o2 8p9xvufl
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-1.1
2ajzhb8hxax
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
y114fzs7gecc1mb
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
n3m1awhzyo 9yq4b
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
qbbq57hbwowrgz
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
zob8yy
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm